BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7246981)

  • 1. Subtle clues to diagnosis of skin diseases by electron microscopy. "Farber bodies" in disseminated lipogranulomatosis (Farber's disease).
    Schmoeckel C
    Am J Dermatopathol; 1980; 2(2):153-6. PubMed ID: 7246981
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Farber's disease--histochemical, electron microscopic and biochemical studies].
    Hamanaka S; Hara A; Otsuka F
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):629-34. PubMed ID: 1920894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Farber's lipogranulomatosis].
    Koga M
    Nihon Rinsho; 1995 Dec; 53(12):3009-13. PubMed ID: 8577050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific ultrastructural marker for disseminated lipogranulomatosis (Faber).
    Schmoeckel C; Hohlfed M
    Arch Dermatol Res; 1979 Oct; 266(2):187-96. PubMed ID: 230790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
    Chen WW; Decker GL
    Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Farber's lipogranulomatosis. Apropos of a case].
    Palcoux JB; Desvignes V; Malpuech G; Charbonne F; Kantelip B; Raynaud EJ
    Arch Fr Pediatr; 1985; 42(7):535-6. PubMed ID: 3936449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farber's disease (lysosomal acid ceramidase deficiency).
    Jameson RA; Holt PJ; Keen JH
    Ann Rheum Dis; 1987 Jul; 46(7):559-61. PubMed ID: 3662645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cherry-red spot is an early sign of Farber's lipogranulomatosis].
    Guseva MR; Pavliuk EIu
    Vestn Oftalmol; 2008; 124(3):51-3. PubMed ID: 18589658
    [No Abstract]   [Full Text] [Related]  

  • 9. Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy.
    Pellissier JF; Berard-Badier M; Pinsard N
    Acta Neuropathol; 1986; 72(2):178-88. PubMed ID: 3103372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular lesions of Farber's disease and their experimental reproduction in tissue culture.
    Rutsaert J; Tondeur M; Vamos-Hurwitz E; Dustin P
    Lab Invest; 1977 May; 36(5):474-80. PubMed ID: 194109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.
    Burck U; Moser HW; Goebel HH; Grüttner R; Held KR
    Eur J Pediatr; 1985 Jan; 143(3):203-8. PubMed ID: 3987715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.
    Pavone L; Moser HW; Mollica F; Reitano C; Durand P
    Johns Hopkins Med J; 1980 Nov; 147(5):193-6. PubMed ID: 7441940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Farber disease [Farber lipogranulomatosis], acid ceramidase deficiency].
    Koga M
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):389-93. PubMed ID: 9645089
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts.
    Dulaney JT; Milunsky A; Sidbury JB; Hobolth N; Moser HW
    J Pediatr; 1976 Jul; 89(1):59-61. PubMed ID: 932904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated lipogranulomatosis (Farber's disease).
    ZETTERSTROM R
    Acta Paediatr (Stockh); 1958 Sep; 47(5):501-10. PubMed ID: 13582627
    [No Abstract]   [Full Text] [Related]  

  • 16. An autopsy case of Farber's lipogranulomatosis in a Japanese boy with gastrointestinal involvement.
    Koga M; Ishihara T; Uchino F; Fujiwaki T
    Acta Pathol Jpn; 1992 Jan; 42(1):42-8. PubMed ID: 1557987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Farber disease: a cause of hoarseness of the voice in children].
    el Sharkawy L; Abdallah H; Marzouk S
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(4):261-5. PubMed ID: 11233710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells.
    Levade T; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
    J Neurol Sci; 1995 Dec; 134(1-2):108-14. PubMed ID: 8747852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disseminated lipogranulomatosis (Farber disease) with hydrops fetalis].
    Schäfer A; Harzer K; Kattner E; Schäfer HJ; Stoltenburg G; Lietz H
    Pathologe; 1996 Mar; 17(2):145-9. PubMed ID: 8650144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farber's disease (disseminated lipogranulomatosis)--a pathological, histochemical and ultrastructural study--.
    Tanaka T; Takahashi K; Hakozaki H; Kimoto H; Suzuki Y
    Acta Pathol Jpn; 1979 Jan; 29(1):135-55. PubMed ID: 219658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.